Delaware
|
84-1070932
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
3800 North 28Th Way
|
||
Hollywood, FL
|
33020
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
Emerging growth company
|
☐
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
Common Stock, par value $0.0001 per share
|
HCMC
|
OTC Pink Marketplace
|
PAGE
|
|
March 31,
2021
|
December 31,
2020
|
||||
ASSETS
|
|||||
CURRENT ASSETS
|
|||||
Cash and cash equivalents
|
$
|
5,316,169
|
$
|
925,475
|
|
Accounts receivable, net
|
56,754
|
23,675
|
|||
Inventories
|
1,700,784
|
1,749,246
|
|||
Prepaid expenses and vendor deposits
|
237,831
|
286,065
|
|||
Investment
|
48,857
|
22,731
|
|||
TOTAL CURRENT ASSETS
|
7,360,395
|
3,007,192
|
|||
Restricted cash
|
-
|
2,000,000
|
|||
Property and equipment, net of accumulated depreciation
|
222,999
|
230,719
|
|||
Intangible assets, net of accumulated amortization
|
1,150,329
|
1,248,352
|
|||
Goodwill
|
916,000
|
916,000
|
|||
Note receivable
|
291,333
|
304,511
|
|||
Right of use asset – operating lease, net
|
3,955,886
|
4,078,621
|
|||
Other assets
|
88,595
|
89,598
|
|||
TOTAL ASSETS
|
$
|
13,985,537
|
$
|
11,874,993
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||
CURRENT LIABILITIES
|
|||||
Accounts payable and accrued expenses
|
$
|
813,870
|
$
|
1,085,663
|
|
Contract liabilities
|
18,170
|
21,262
|
|||
Current portion of line of credit
|
-
|
2,000,000
|
|||
Current portion of loan payment
|
842,228
|
2,072,484
|
|||
Operating lease liability, current
|
483,482
|
474,686
|
|||
TOTAL CURRENT LIABILITIES
|
2,157,750
|
5,654,095
|
|||
Loan payable, net of current portion
|
778,411
|
849,009
|
|||
Operating lease liability, net of current
|
3,001,335
|
3,114,521
|
|||
TOTAL LIABILITIES
|
5,937,496
|
9,617,625
|
|||
COMMITMENTS AND CONTINGENCIES (SEE NOTE 10)
|
|||||
STOCKHOLDERS’ EQUITY
|
|||||
Series C convertible preferred stock, $1,000 par value per share, 30,000 shares authorized; 0 and 16,277
shares issued and outstanding as of March 31, 2021 and December 31, 2020; aggregate liquidation preference of $- million
|
-
|
16,277,116
|
|||
Series D convertible preferred stock, $1,000 par value per share, 5,000 shares authorized; 5,000 shares
issued and outstanding as of March 31, 2021; aggregate liquidation preference of $5.0 million
|
5,000,000
|
-
|
|||
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; approximately 307.7 and 143.8
billion shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively
|
30,772,608
|
14,384,084
|
|||
Additional paid-in capital
|
5,330,562
|
3,955,039
|
|||
Accumulated deficit
|
(33,055,129)
|
(32,358,871)
|
|||
TOTAL STOCKHOLDERS’ EQUITY
|
8,048,041
|
2,257,368
|
|||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
13,985,537
|
$
|
11,874,993
|
Three Months Ended March 31,
|
|||||
2021
|
2020
|
||||
SALES
|
|||||
Vapor sales, net
|
$
|
613,936
|
$
|
773,458
|
|
Grocery sales, net
|
2,851,817
|
3,262,714
|
|||
TOTAL SALES, NET
|
3,465,753
|
4,036,172
|
|||
Cost of sales vapor
|
233,315
|
319,080
|
|||
Cost of sales grocery
|
1,741,728
|
2,009,200
|
|||
GROSS PROFIT
|
1,490,710
|
1,707,892
|
|||
OPERATING EXPENSES
|
2,022,883
|
2,372,381
|
|||
LOSS FROM OPERATIONS
|
(532,173)
|
(664,489)
|
|||
OTHER (EXPENSE) INCOME
|
|||||
Gain (loss) on investment
|
26,126
|
(9,857)
|
|||
Other expense, net
|
-
|
(76)
|
|||
Interest expense, net
|
(72,915)
|
(16,872)
|
|||
Loss on extinguishment of debt
|
(117,296)
|
-
|
|||
Total other expense, net
|
(164,085)
|
(26,805)
|
|||
NET LOSS
|
$
|
(696,258)
|
$
|
(691,294)
|
|
NET LOSS PER SHARE-BASIC AND DILUTED
|
$
|
0.00
|
$
|
0.00
|
|
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND DILUTED
|
244,246,983,178
|
69,716,324,179
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – January 1, 2021
|
16,277
|
$
|
16,277,116
|
143,840,848,017
|
$
|
14,384,084
|
$
|
3,955,039
|
$
|
(32,358,871)
|
$
|
2,257,368
|
||||||||
Series C Convertible Preferred Stock exercised
|
(16,277)
|
(16,277,116)
|
162,771,153,001
|
16,277,116
|
-
|
-
|
-
|
|||||||||||||
Stock options exercised
|
-
|
-
|
775,000,000
|
77,500
|
-
|
-
|
77,500
|
|||||||||||||
Issuance of Series D Preferred stock in connection with the Securities Purchase Agreement
|
5,000
|
5,000,000
|
-
|
-
|
-
|
-
|
5,000,000
|
|||||||||||||
Issuance of common stock
|
-
|
-
|
1,182,831,056
|
118,283
|
1,289,273
|
-
|
1,407,556
|
|||||||||||||
Issuance of awarded stock for officers
|
-
|
-
|
2,200,000,000
|
220,000
|
(220,000)
|
-
|
-
|
|||||||||||||
Issuance of awarded stock for board member
|
-
|
-
|
50,000,000
|
5,000
|
(5,000)
|
-
|
-
|
|||||||||||||
Cancellation of awarded stock for officers
|
-
|
-
|
(3,025,000,000)
|
(302,500)
|
302,500
|
-
|
-
|
|||||||||||||
Cancellation of awarded stock for board member
|
-
|
-
|
(68,750,000)
|
(6,875)
|
6,875
|
-
|
-
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
1,875
|
-
|
1,875
|
|||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(696,258)
|
(696,258)
|
|||||||||||||
Balance – March 31, 2021
|
5,000
|
$
|
5,000,000
|
307,726,082,074
|
$
|
30,772,608
|
$
|
5,330,562
|
$
|
(33,055,129)
|
$
|
8,048,041
|
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – January 1, 2020
|
20,150
|
$
|
20,150,116
|
67,698,494,244
|
$
|
6,769,849
|
$
|
7,618,245
|
$
|
(28,636,479)
|
$
|
5,901,731
|
||||||||
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
4,798,932,767
|
479,894
|
(479,894)
|
-
|
-
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
81,944
|
-
|
81,944
|
|||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(691,294)
|
(691,294)
|
|||||||||||||
Balance – March 31, 2020
|
20,150
|
$
|
20,150,116
|
72,497,427,011
|
$
|
7,249,743
|
$
|
7,220,295
|
$
|
(29,327,773)
|
$
|
5,292,381
|
Three Months Ended March 31,
|
|||||
2021
|
2020
|
||||
OPERATING ACTIVITIES
|
|||||
Net loss
|
$
|
(696,258)
|
$
|
(691,294)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|||||
Depreciation and amortization
|
136,597
|
147,834
|
|||
Loss on extinguishment of debt
|
117,296
|
-
|
|||
Loss (Gain) on investment
|
(26,126)
|
9,857
|
|||
Amortization of right-of-use asset
|
122,735
|
158,724
|
|||
Stock-based compensation expense
|
1,875
|
81,944
|
|||
Changes in operating assets and liabilities:
|
|||||
Accounts receivable
|
(33,079)
|
(1,081)
|
|||
Inventories
|
48,462
|
40,036
|
|||
Prepaid expenses and vendor deposits
|
48,234
|
21,171
|
|||
Other assets
|
1,003
|
3,958
|
|||
Accounts payable
|
(146,862)
|
126,569
|
|||
Accrued expenses
|
(122,765)
|
47,124
|
|||
Contract liabilities
|
(3,092)
|
(3,756)
|
|||
Lease liability
|
(104,390)
|
(140,374)
|
|||
NET CASH USED IN OPERATING ACTIVITIES
|
(656,370)
|
(199,288)
|
|||
INVESTING ACTIVITIES
|
|||||
Collection of note receivable
|
13,178
|
7,362
|
|||
Purchases of property and equipment
|
(30,855)
|
(10,805)
|
|||
Purchases of patent
|
-
|
(89,415)
|
|||
NET CASH USED IN INVESTING ACTIVITIES
|
(17,677)
|
(92,858)
|
|||
FINANCING ACTIVITIES
|
|||||
Principal payments on loan payable
|
(12,759)
|
(70,574)
|
|||
Principal payment on the line of credit
|
(2,000,000)
|
-
|
|||
Proceeds from security purchase agreement
|
5,000,000
|
-
|
|||
Proceeds from exercise of stock options
|
77,500
|
-
|
|||
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
3,064,741
|
(70,574)
|
|||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENT AND RESTRICTED CASH
|
2,390,694
|
(362,720)
|
|||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH— BEGINNING OF PERIOD
|
2,925,475
|
3,525,415
|
|||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — END OF PERIOD
|
$
|
5,316,169
|
$
|
3,162,695
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|||||
Cash paid for interest
|
$
|
81,313
|
$
|
35,256
|
|
NON-CASH INVESTING AND FINANCING ACTIVITIES
|
|||||
Issuance of common stock
|
$
|
1,407,556
|
$
|
-
|
|
March 31, 2021
|
December 31, 2020
|
||||||
Cash and Cash Equivalent
|
$
|
5,316,169
|
$
|
925,475
|
||||
Restricted cash, non-current portion
|
-
|
2,000,000
|
||||||
Total cash, cash equivalents and restricted cash
|
$
|
5,316,169
|
$
|
2,925,475
|
Three Months Ended March 31,
|
||||||||
2021
|
2020
|
|||||||
Vapor
|
$
|
613,936
|
$
|
773,458
|
||||
Grocery
|
2,851,817
|
3,262,714
|
||||||
Total revenue
|
$
|
3,465,753
|
$
|
4,036,172
|
||||
Retail Vapor
|
$
|
613,894
|
$
|
773,458
|
||||
Retail Grocery
|
2,542,360
|
2,830,365
|
||||||
Food service/restaurant
|
287,722
|
329,139
|
||||||
Online/eCommerce
|
13,717
|
103,210
|
||||||
Wholesale Grocery
|
8,018
|
-
|
||||||
Wholesale Vapor
|
42
|
-
|
||||||
Total revenue
|
$
|
3,465,753
|
$
|
4,036,172
|
March 31, 2021
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
Trade names
|
8-10 years
|
$
|
923,000
|
$
|
(465,505)
|
$
|
457,495
|
|||||
Customer relationships
|
4-10 years
|
883,000
|
(529,510)
|
353,490
|
||||||||
Patents
|
10 years
|
359,665
|
(94,633)
|
265,032
|
||||||||
Non-compete
|
4 years
|
174,000
|
(99,688)
|
74,312
|
||||||||
Intangible assets, net
|
$
|
2,339,665
|
$
|
(1,189,336)
|
$
|
1,150,329
|
December 31, 2020
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
Trade names
|
8-10 years
|
$
|
923,000
|
(441,786)
|
$
|
481,214
|
||||||
Customer relationships
|
4-10 years
|
883,000
|
(475,073)
|
407,927
|
||||||||
Patents
|
10 years
|
359,665
|
(85,641)
|
274,024
|
||||||||
Non-compete
|
4 years
|
174,000
|
(88,813)
|
85,187
|
||||||||
Intangible assets, net
|
$
|
2,339,665
|
$
|
(1,091,313)
|
$
|
1,248,352
|
Years ending December 31,
|
||||
2021 (remaining nine months)
|
$
|
287,069
|
||
2022
|
369,706
|
|||
2023
|
130,841
|
|||
2024
|
130,841
|
|||
2025
|
125,341
|
|||
Thereafter
|
106,531
|
|||
Total
|
$
|
1,150,329
|
As of March 31,
|
||||||||
2021
|
2020
|
|||||||
Beginning balance as January 1,
|
$
|
21,262
|
$
|
26,823
|
||||
Issued
|
46,627
|
60,309
|
||||||
Redeemed
|
(49,585
|
)
|
(63,509
|
)
|
||||
Breakage recognized
|
(134
|
)
|
(556
|
)
|
||||
Ending balance as of March 31,
|
$
|
18,170
|
$
|
23,067
|
_
|
Due Date
|
Interest Rate
|
March 31, 2021
|
December 31, 2020
|
||||||
Term Loan Credit Agreement
|
December 2023
|
7.00%
|
$
|
730,924
|
$
|
800,924
|
||||
Paycheck Protection Program
|
May 2022
|
1%
|
884,431
|
882,264
|
||||||
Line of Credit
|
July 2021
|
2.2%
|
-
|
2,000,000
|
||||||
Loan and Security Agreement ("PPE Loan")
|
March 2021
|
5%
|
-
|
1,232,414
|
||||||
Other debt
|
April 2023
|
5.3%
|
5,284
|
5,891
|
||||||
Total debt
|
$
|
1,620,639
|
4,921,493
|
As of March 31,
|
||||||||
2021
|
2020
|
|||||||
Preferred stock
|
2,083,000,000
|
201,501,000,000
|
||||||
Stock options
|
69,087,000,000
|
68,062,000,000
|
||||||
Warrants
|
-
|
36,460,000,000
|
||||||
Total
|
71,170,000,000
|
306,023,000,000
|
Three Months Ended March 31,
|
2020 to 2021
|
|||||||
2021
|
2020
|
Change $
|
||||||
SALES
|
||||||||
Vapor sales, net
|
$
|
613,936
|
$
|
773,458
|
$
|
(159,522)
|
||
Grocery sales, net
|
2,851,817
|
3,262,714
|
(410,897)
|
|||||
TOTAL SALES, NET
|
3,465,753
|
4,036,172
|
(570,419)
|
|||||
Cost of sales vapor
|
233,315
|
319,080
|
(85,765)
|
|||||
Cost of sales grocery
|
1,741,728
|
2,009,200
|
(267,472)
|
|||||
GROSS PROFIT
|
1,490,710
|
1,707,892
|
(217,182)
|
|||||
OPERATING EXPENSES
|
2,022,883
|
2,372,381
|
(349,498)
|
|||||
LOSS FROM OPERATIONS
|
(532,173)
|
(664,489)
|
132,316
|
|||||
OTHER INCOME (EXPENSE)
|
||||||||
Gain (loss) on investment
|
26,126
|
(9,857)
|
35,983
|
|||||
Other expense, net
|
-
|
(76)
|
76
|
|||||
Interest expense, net
|
(72,915)
|
(16,872)
|
(56,043)
|
|||||
Loss on extinguishment of debt
|
(117,296)
|
-
|
(117,296)
|
|||||
Total other expense, net
|
(164,085)
|
(26,805)
|
(137,280)
|
|||||
NET LOSS
|
$
|
(696,258)
|
$
|
(691,294)
|
$
|
(4,964)
|
Three Months Ended March 31,
|
|||||
2021
|
2020
|
||||
Net cash provided by (used in)
|
|||||
Operating activities
|
$
|
(656,370)
|
$
|
(199,288)
|
|
Investing activities
|
(17,677)
|
(92,858)
|
|||
Financing activities
|
3,064,741
|
(70,574)
|
|||
$
|
2,390,694
|
$
|
(362,720)
|
March 31, 2021
|
December 31, 2020
|
||||
Cash
|
$
|
5,316,169
|
$
|
925,475
|
|
Total assets
|
$
|
13,985,537
|
$
|
11,874,993
|
|
Percentage of total assets
|
38.01%
|
7.79%
|
● |
Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over financial
reporting
|
● |
Weakness around our purchase orders and inventory write-off procedures
|
● |
Segregation of duties due to lack of personnel
|
● |
Management continues to devote significant efforts toward improvement of effectiveness of control over financial reporting. This includes analyzing non-routine
transactions before booking journal entries; Implemented a monthly variance fluctuation analysis across all segments. Variance analysis are communicated to operations and executives to make sure the results are accurate.
|
● |
Our management has increased its focus on the Company’s purchase order process in order to better manage inventory thereby improving cash management and ultimately
leading to more reliable and precise financial reporting.
|
● |
Vendor payments and cash disbursement are reviewed on weekly basis by management and accounting team to ensure timely payment. Cash balance are communicated to
management on weekly basis to improve cash management.
|
Exhibit
|
Incorporated by Reference
|
Filed or Furnished
|
||||||||
No.
|
Exhibit Description
|
Form
|
Date
|
Number
|
Herewith
|
|||||
31.1
|
Filed
|
|||||||||
31.2
|
Filed
|
|||||||||
32.1
|
Furnished *
|
|||||||||
32.2
|
Furnished *
|
|||||||||
101.INS
|
XBRL Instance Document
|
Filed
|
||||||||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Filed
|
||||||||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Filed
|
||||||||
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Filed
|
||||||||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Filed
|
||||||||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Filed
|
* |
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
HEALTHIER CHOICES MANAGEMENT CORP.
|
||
Date: May 10, 2021
|
By:
|
/s/ Jeffrey Holman
|
Jeffrey Holman
|
||
Chief Executive Officer
|
||
Date: May 10, 2021
|
By:
|
/s/ John Ollet
|
John Ollet
|
||
Chief Financial Officer
|